🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, cross over study aims to find out the benefits of deliveri...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-20
Trial ID
NCT03227445
Treatments Being Tested
GSK233705 is a high-affinity specific muscarinic receptor (mAChR) antagonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-12-12
Trial ID
NCT00279019
Treatments Being Tested
The purpose of this study is to identify the optimal once-daily dose of CHF...
Status
Completed
Location
Clopton Clinic
Start Date
2006-10
Trial ID
NCT00605891
Treatments Being Tested
COPD is characterized by an airflow limitation, which is not fully reversib...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-06-16
Trial ID
NCT03034915
This study investigated the effect of exercise and high-dose salbutamol on ...
Status
Completed
Location
Novartis Investigative site
Start Date
2007-08
Trial ID
NCT00531050
Treatments Being Tested
This study is a multi-centre, randomised, double-blind, placebo-controlled ...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-10-01
Trial ID
NCT02567708
Treatments Being Tested
The primary objective of this study is to evaluate the dose response, effic...
Status
Completed
Location
Teva Investigational Site 10504
Start Date
2012-04
Trial ID
NCT01576718
Treatments Being Tested
GSK2245035 belongs to a novel class of agonist drugs targeted at toll like ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-01-21
Trial ID
NCT03707678
Treatments Being Tested
This is a randomized, multi-centre, open-label, placebo-device, cross-over ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-30
Trial ID
NCT02982187
Treatments Being Tested
This is a randomized, double-blind, placebo- and open-label active controll...
Status
Completed
Location
Teva Investigational Site 10165
Start Date
2012-01
Trial ID
NCT01479621
Treatments Being Tested